4//SEC Filing
McDowell Caryn Gordon 4
Accession 0001479290-20-000033
CIK 0001479290other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:23 PM ET
Size
5.1 KB
Accession
0001479290-20-000033
Insider Transaction Report
Form 4
McDowell Caryn Gordon
SVP, GC & Secretary
Transactions
- Tax Payment
Common Stock
2020-02-15$25.33/sh−864$21,885→ 23,453 total
Footnotes (2)
- [F1]Represents the number of shares withheld by and surrendered to the Issuer on February 15, 2020, to satisfy tax withholding obligations that arose in connection with the vesting of a Restricted Stock Award ("RSA") for 2,500 shares. The RSA vests in three equal annual installments from February 15, 2019, subject to Mrs. McDowell's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the "Plan")) on each vesting date.
- [F2]The fair market value was determined on February 14, 2020 pursuant to the Plan.
Documents
Issuer
Revance Therapeutics, Inc.
CIK 0001479290
Entity typeother
Related Parties
1- filerCIK 0001674232
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:23 PM ET
- Size
- 5.1 KB